News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Article Jun 30, 2023 What is the Difference between Biostatistics and Statistics? In the life sciences field, there are two terms that often come up when describing the analysis of data; biostatistics and statistics, which are often… Read Now
News Jun 26, 2023 Alimentiv Inc. launches Alimentiv Statistics London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the… Read Now
Article Apr 18, 2023 Pharmacokinetics vs Pharmacodynamics: Understanding their role in Drug Discovery Pharmacokinetics vs Pharmacodynamics: each play a crucial role in the drug discovery process by providing insight into how drugs work in the body and how… Read Now
Article Mar 21, 2023 A Practical Look at Sample Size Re-Estimation of the Promising Zone Design The randomized controlled clinical trial (RCT) with a fixed design has become a gold standard for evaluating drug safety and efficacy since its debut. However,… Read Now
Article Jan 20, 2023 The Ultimate Glossary of Clinical Study Design & Statistical Analysis Terms At Alimentiv, we place a high priority on educating our audience and clients about clinical statistical analysis and trial design. As such, we decided it was… Read Now
News Nov 3, 2022 Alimentiv, Summit Clinical Research Announce Collaboration to drive Non-Alcoholic Steatohepatitis (NASH) Clinical Trials London, Ontario, Canada, November 3, 2022, Alimentiv Inc. (“Alimentiv”) and Summit Clinical Research, LLC (“Summit”) today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis (NASH)… Read Now
